AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (469.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Ciprofloxacin stress changes key enzymes and intracellular metabolites of Lactobacillus plantarum DNZ-4

Pin ChenaXiaoqian ChenaWei YuaBo ZhouaLihua LiubYuzhuo YangcPeng DuaLibo Liua( )Chun Lia( )
Key Laboratory of Dairy Science, Ministry of Education, Food Science College, Northeast Agricultural University, Harbin 150030, China
Institute of Animal Science (IAS), Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China
National Dairy Product Quality Supervision and Inspection Center, Harbin 150024, China
Show Author Information

Abstract

Ciprofloxacin (CIP) is an antibiotic used to treat infections caused by bacteria. In this experiment, key enzymes and intracellular metabolites of Lactobacillus plantarum DNZ-4 was researched under CIP stress. The results showed that the activities of hexokinase, pyruvate kinase, β-galactosidase and Na+, K+-ATPase after 1/2 minimum bacteriostatic concentration (MIC) CIP treatment were significantly decreased (P < 0.01). Gas chromatography-mass spectrometry was used to analysis the changes of main metabolites in the cells and principal component analysis and partial least square model were constructed. The results indicated that CIP could cause changes in intracellular fatty acids, carbohydrates and amino acids, and the mechanism of amino acid metabolism under CIP stress was significantly inhibited. L. plantarum DNZ-4 made stress response to CIP by regulating the ratio of saturated fatty acids and unsaturated fats. This experiment revealed the changes of growth and metabolism mechanism of L. plantarum DNZ-4 under CIP stress, which help to provide technical means for the development of effective probiotics preparation products.

References

[1]

H.A. Seddik, F. Bendali, F. Gancel, et al., Lactobacillus plantarum and its probiotic and food potentialities, Probiotics & Antimicro. Prot. 31 (2017) 88-93. https://doi.org/10.1007/s12602-017-9264-z.

[2]

M. Kleerebezem, P. Hols, J. Hugenholtz, Lactic acid bacteria as a cell factory: rerouting of carbon metabolism in Lactococcus lactis by metabolic engineering, Enzyme Microb. Technol. 26 (2000) 840-848. https://doi.org/10.1016/S0141-0229(00)00180-0.

[3]

M.V. Arasu, N.A. Aldhabi, S. Ilavenil, et al., In vitro importance of probiotic Lactobacillus plantarum related to medical field, Saudi J. Biol. Sci. 23 (2016) 372-389. https://doi.org/10.1016/j.sjbs.2015.09.022.

[4]

W. Wang, J. He, D. Pan, et al., Metabolomics analysis of Lactobacillus plantarum ATCC 14917 adhesion activity under initial acid and alkali stress, PLoS One 13 (2018) 447-489. https://doi.org/10.1371/journal.pone.0196231.

[5]

D.M. Campoli-Richards, J.P. Monk, A. Price, et al., Ciprofloxacin, Drugs 35 (1988) 373-447.

[6]

R. Davis, A. Markham, J. Balfour, Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability, Drugs 51 (1986) 1019-1074. https://doi.org/10.2165/00003495-199651060-00010.

[7]

J. Machuca, E. Recacha, A. Briales, et al., Cellular response to ciprofloxacin in low-level quinolone-resistant Escherichia coli, Front. Microbiol. 8 (2017) 483-492. https://doi.org/10.3389/fmicb.2017.01370.

[8]

D.I. Andersson, D. Hughes, Microbiological effects of sublethal levels of antibiotics, Nat. Rev. Microbiol. 12 (2014) 465-478. https://doi.org/10.1038/nrmicro3270.

[9]

R.N. Klitgaard, J. Bimal, G. Luca, et al., DNA damage repair and drug efflux as potential targets for reversing low or intermediate ciprofloxacin resistance in E. coli K-12, Front. Microbiol. 9 (2018) 1438-1467. https://doi.org/10.3389/fmicb.2018.01438.

[10]

R.J. Carman, M.A. Woodburn, Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora, Regul. Toxicol. Pharmacol. 33 (2001) 276-284. https://doi.org/10.1006/rtph.2001.1473.

[11]

J. Weigelt, L.D. Mcbroomcerajewski, M. Schapira, et al., Erratum to: 'structural genomics and drug discovery: all in the family, Curr. Opin. Chem. Biol. 13 (2009) 132.

[12]

S. Rochfort, Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research, J. Nat. Prod. 68 (2005) 1813-1820. https://doi.org/10.1021/np050255w.

[13]

Y. Hu, S. Zhang, Z. Xu, et al. 4-Quinolone hybrids and their antibacterial activities, Eur. J. Med. Chem. 141 (2017) 335-345. https://doi.org/10.1016/j.ejmech.2017.09.050.

[14]

S. Correia, M. Hebraud, I. Chafsey, et al., Comparative subproteomic analysis of clinically acquired fluoroquinolone resistance and ciprofloxacin stress in Salmonella Typhimurium DT104B, Proteom. Clin. Appl. 11 (2017) 1600-1607. https://doi.org/10.1002/prca.201600107.

[15]

W. Li, S. Zhang, X. Wang, et al., Systematically integrated metabonomic-proteomic studies of Escherichia coli under ciprofloxacin stress, J. Proteomics 179 (2018) 61-70. https://doi.org/10.1016/j.jprot.2018.03.002.

[16]

B. Shan, Y. Cai, J.D. Brooks, et al., Antibacterial properties of Polygonum cuspidatum roots and their major bioactive constituents, Food Chem. 109 (2008) 530-537. https://doi.org/10.1016/j.foodchem.2007.12.064.

[17]

I.B. Pavlova, D.A. Bannikova, A.B. Kononenko, et al., Electron microscopy study of interaction of lactic acid bacteria with pathogenic microorganisms, Russ. Agricult. Sci. 39 (2013) 179-183. https://doi.org/10.3103/S106836741302016X.

[18]

J.L. Brunelle, R. Green, Coomassie blue staining, Methods Enzymol. 541 (2014) 161-167.

[19]

D.C. Hooper, G.A. Jacoby, Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance, Cold Spring Harb. Perspect. Med. 6 (2016) 189-196. https://doi.org/10.1101/cshperspect.a025320.

[20]
T. Dorr, K. Lewis, M. Vulic, SOS response induces persistence to fluoroquinolones in Escherichia coli, PLoS Genet. 5 (2009) 647-665. https://doi.org/110.1371/journal.pgen.1000760.
[21]

S.M. Smith, R.H.K. Eng, Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother. 27 (1985) 688-691. https://doi.org/10.1128/AAC.27.5.688.

[22]

B. Nanduri, M.L. Lawrence, C.R. Boyle, et al., Effects of subminimum inhibitory concentrations of antibiotics on the pasteurella multocida proteome: a systems approach, Comp. Funct. Genomics. 5 (2006) 572-580. https://doi.org/10.1021/pr050360r.

[23]

D.J. Cabral, J.I. Wurster, P. Belenky, Antibiotic persistence as a metabolic adaptation: stress, metabolism, the host, and new directions, Antimicrob. Agents Chemother. 11 (2018) 14-28. https://doi.org/10.3390/ph11010014.

[24]

J.L. Brown, S. Koorajian, J. Katze, et al., β-Galactosidase, J. Biol. Chem. 241 (1966) 2826-2831.

[25]

M.V. Tselevych, S.M. Mandzynets, D.I. Sanahursky, Effect of antibiotics on Na(+), K(+)-ATP-ase activity of the membranes in the Misgurnus fossilis L. embryos, Fiziol Zh. 50 (2004) 64-68.

[26]

R. Zemelman, M.A. Mondaca, A. Neira, et al., Bacterial cell characteristics that contribute to antibiotic resistance, Arch. Med. Vet. 13 (1980) 233-245.

[27]

S. Even, N.D. Lindley, P. Loubière, et al., Dynamic response of catabolic pathways to autoacidification in Lactococcus lactis: transcript profiling and stability in relation to metabolic and energetic constraints, Mol. Microbiol. 45 (2002) 58-78. https://doi.org/10.1046/j.1365-2958.2002.03086.x.

[28]

W.N. Konings, J.S. Lolkema, H. Bolhuis, et al., The role of transport processes in survival of lactic acid bacteria, energy transduction and multidrug resistance, Anton. Leeuw. Int. J. G. 71 (1997) 117-128. https://doi.org/10.1023/a:1000143525601.

[29]

L.N. Churkina, Z.P. Vasiurenko, V.V. Smirnov, et al., Effect of antibiotic AL-87 on the fatty acid composition of microorganisms in different taxonomic groups, Antibiotiki. 28 (1983) 489-502.

[30]

V.V. Smirnov, L.N. Churkina, Z.P. Vasiurenko, Antibiotic AL-87 induction of changes in the fatty acid composition of phospholipids and neutral lipids in a sensitive strain of Staphylococcus aureus 209P, Antibiot Chemother. 33 (1988) 440-448.

[31]

E.P. Feofilova, A.I. Usov, I.S. Mysyakina, et al., Trehalose: chemical structure, biological functions, and practical application, Microbiology 83 (2014) 184-194. https://doi.org/10.1134/S0026261714020064.

[32]

M.F. Roberts, Inositol in bacteria and archaea, Sub-cell Biochem. 39 (2006) 103-133.

[33]

M. Fernández, M. Zúñiga, Amino acid catabolic pathways of lactic acid bacteria, Crit. Rev. Microbiol. 32 (2006) 155-174. https://doi.org/10.1080/10408410600880643.

[34]

D. Banerjee, D. Parmar, N. Bhattacharya, et al., A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance, BMC Syst. Biol. 11 (2017) 51-64. https://doi.org/10.1186/s12918-017-0427-z.

[35]

P. Belenky, J.D. Ye, C.B. Porter, et al., Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage, Cell Rep. 13 (2015) 968-980. https://doi.org/10.1016/j.celrep.2015.09.059.

[36]

B. Zhang, S.M. Halouska, C.E. Schiaffo, et al., NMR analysis of a stress response metabolic signaling network, J. Proteome Res. 10 (2011) 3743-3754. https://doi.org/10.1021/pr200360w.

[37]

K.K. Suresh, S.D. Bhosale, H.V. Thulasiram, et al., Comparative and chemical proteomic approaches reveal gatifloxacin deregulates enzymes involved in glucose metabolism, J. Toxicol. Sci. 36 (2011) 787-796. https://doi.org/10.2131/jts.36.787.

Food Science and Human Wellness
Pages 332-340
Cite this article:
Chen P, Chen X, Yu W, et al. Ciprofloxacin stress changes key enzymes and intracellular metabolites of Lactobacillus plantarum DNZ-4. Food Science and Human Wellness, 2022, 11(2): 332-340. https://doi.org/10.1016/j.fshw.2021.11.007

689

Views

39

Downloads

3

Crossref

3

Web of Science

4

Scopus

0

CSCD

Altmetrics

Received: 08 July 2020
Revised: 04 November 2020
Accepted: 19 January 2021
Published: 25 November 2021
© 2022 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return